Fondation pour l’Innovation
en Cardiométabolisme et Nutrition

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study

European Heart Journal – Cardiovascular Pharmacotherapy

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study

CERTIFIÉ ISO 9001

Nos soutiens institutionnels

Notre réseau